Medical Journals

Deficiency in the Repair of Dna Damage by Homologous Recombination and Sensitivity to Poly(Adp-ribose) Polymerase Inhibition.

Authors:
  • McCabe Nuala
  • Turner Nicholas C
  • Lord Christopher J
  • Kluzek Katarzyna
  • Bialkowska Aneta
  • Swift Sally
  • Giavara Sabrina
  • O’Connor Mark J
  • Tutt Andrew N
  • Zdzienicka MaƂgorzata Z
  • Smith Graeme C M
  • Ashworth Alan

From: Cancer Research UK Gene Function and Regulation Group and The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom.

Cancer research

  • Publish Date: Aug 2006
  • ISSN: 1538-7445
  • Volume: 66
  • Issue: 16
  • Pages: 8109-15
  • Medium: Internet
  • Language: English
  • Citation (JAMA): McCabe Nuala, Turner Nicholas C, Lord Christopher J, et al. Deficiency in the Repair of Dna Damage by Homologous Recombination and Sensitivity to Poly(Adp-ribose) Polymerase Inhibition.. Cancer Res. Aug 2006;66:8109-15

Abstract

Deficiency in either of the breast cancer susceptibility proteins BRCA1 or BRCA2 induces profound cellular sensitivity to the inhibition of poly(ADP-ribose) polymerase (PARP) activity. We hypothesized that the critical role of BRCA1 and BRCA2 in the repair of double-strand breaks by homologous recombination (HR) was the underlying reason for this sensitivity. Here, we examine the effects of deficiency of several proteins involved in HR on sensitivity to PARP inhibition. We show that deficiency of RAD51, RAD54, DSS1, RPA1, NBS1, ATR, ATM, CHK1, CHK2, FANCD2, FANCA, or FANCC induces such sensitivity. This suggests that BRCA-deficient cells are, at least in part, sensitive to PARP inhibition because of HR deficiency. These results indicate that PARP inhibition might be a useful therapeutic strategy not only for the treatment of BRCA mutation-associated tumors but also for the treatment of a wider range of tumors bearing a variety of deficiencies in the HR pathway or displaying properties of ‘BRCAness.’

Mesh Headings (Keywords): Animals, BRCA1 Protein, BRCA2 Protein, DNA Damage, DNA Repair, Embryo, Mammalian, Enzyme Inhibitors, Fluorobenzenes, Mice, Mice, Knockout, Phthalazines, Poly(ADP-ribose) Polymerases, Recombination, Genetic, Stem Cells


Check for Full Text / PubMed Unique Identifier (PMID): 16912188


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.